Treatment of breast sarcomas. Review of literature
Breast sarcomas are spectrum of heterogeneous sarcomas in breast and the optimal treatment is still under discussion. We retrospectively reviewed 51 patient with BS between 1999 and 2014 in N.N. Blokhin Russian Cancer Research Center Ministry of Health of the Russian Federation. With median follow up of 86,4 months, 43,14% of patients (22/51) developed local recurrence and metastasis. Five year recurrence free survival and OS rate were 37,5 and 56,2%, respectively. Disease stage and local recurrence were indicated as unfavorable prognostic factors. Surgery remains a crucial treatment for breast sarcomas. Mastectomy is not routinely necessary if clear margin could be achieved by local excision.